Literature DB >> 11732586

Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability.

H Okamura1, H Katabuchi.   

Abstract

Ovarian epithelial tumors are thought to derive from the surface epithelium of the ovary, which differentiates after invagination of the coelomic mesothelium over the gonadal ridges during early embryonic development. On the putative mullerian potential of this epithelium, endometriosis, including ovarian endometriosis, can be explained by a metaplastic process from the peritoneum. In the present study, we assessed specific changes in the architecture and in the cytological characteristics of human ovarian epithelial cells on the surface and within the inclusion cyst. Grossly normal ovaries were retrieved from 215 patients undergoing incidental oophorectomy and 33 patients with contralateral ovarian tumor. In addition, 75 patients diagnosed with epithelial ovarian cancer and 26 ovarian endometriosis patients undergoing oophorectomy were selected. The incidence of cortical invagination, epithelial papillomatosis and pseudostratification was not different in normal ovaries between pre- and post-menopausal women, whereas inclusion cysts were more frequently observed in post-menopausal women (p<0.05). The occurrence rates of invagination and inclusion cysts were significantly higher in normal ovaries examined after incidental oophorectomy (p<0.05) and in those with contralateral ovarian tumor (p<0.05), respectively. Although serous metaplastic change with cilia was most common and it did not differ before and after menopause, the frequency of mucinous, endometrioid and transitional cell changes was low in the two groups of pre- and post-menopausal women. Mucinous metaplasia was more frequently observed in patients with contralateral ovarian tumor than those without ovarian tumor (12.1% vs. 1.9%; p<0.05). Four (5.3%) of 75 ovarian cancer patients revealed malignant transformed cells from a single layer of normal epithelium covering the ovarian surface or inclusion cyst. Ovarian or extraovarian endometriosis was identified in 16 (21.3%) of 75 epithelial ovarian cancer patients analyzed. An in situ carcinogenesis in the endometriotic cyst was seen in three epithelial ovarian cancers (4.0%). In seven (26.9%) of 26 ovarian endometriosis cases, epithelial cells on the ovarian surface or within the inclusion cyst were histologically changed to endometriotic gland cells. Careful and extensive observations of surgical specimens with ovarian carcinoma and ovarian endometriosis showed that they originated from the ovarian epithelium lining the surface and cortical small cysts.

Entities:  

Mesh:

Year:  2001        PMID: 11732586

Source DB:  PubMed          Journal:  Ital J Anat Embryol        ISSN: 1122-6714


  9 in total

1.  Asian society of gynecologic oncology workshop 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Mohamad Farid Aziz; Uma K Devi; Hextan Y S Ngan; Joo-Hyun Nam; Seung Cheol Kim; Tomoyasu Kato; Hee Sug Ryu; Shingo Fujii; Yoon Soon Lee; Jong Hyeok Kim; Tae-Joong Kim; Young Tae Kim; Kung-Liahng Wang; Taek Sang Lee; Kimio Ushijima; Sang-Goo Shin; Yin Nin Chia; Sarikapan Wilailak; Sang Yoon Park; Hidetaka Katabuchi; Toshiharu Kamura; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  In vitro three-dimensional modelling of human ovarian surface epithelial cells.

Authors:  K Lawrenson; E Benjamin; M Turmaine; I Jacobs; S Gayther; D Dafou
Journal:  Cell Prolif       Date:  2009-04-24       Impact factor: 6.831

3.  Ovarian Cancer Is an Imported Disease: Fact or Fiction?

Authors:  Elisabetta Kuhn; Robert J Kurman; Ie-Ming Shih
Journal:  Curr Obstet Gynecol Rep       Date:  2012-03

4.  Fallopian tube correlates of ovarian serous borderline tumors.

Authors:  Anna R Laury; Gang Ning; Charles M Quick; Jonathan Bijron; Mana M Parast; Rebeca A Betensky; Sara O Vargas; Frank D McKeon; Wa Xian; Marisa R Nucci; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2011-12       Impact factor: 6.394

Review 5.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

6.  HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.

Authors:  Anna Fritz-Rdzanek; Wojciech Grzybowski; Jarosław Beta; Andrzej Durczyński; Artur Jakimiuk
Journal:  Oncol Lett       Date:  2012-06-13       Impact factor: 2.967

7.  Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomas.

Authors:  Dong-Joo Cheon; Ann E Walts; Jessica A Beach; Jenny Lester; John S Bomalaski; Christine S Walsh; W Ruprecht Wiedemeyer; Beth Y Karlan; Sandra Orsulic
Journal:  J Pathol Clin Res       Date:  2014-11-05

Review 8.  A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen Gallus gallus.

Authors:  Purab Pal; Kara Nicole Starkweather; Karen Held Hales; Dale Buchanan Hales
Journal:  Comp Med       Date:  2021-07-29       Impact factor: 0.982

9.  Therapeutic Role of Annona muricata Fruit and Bee Venom Against MNU-Induced Breast Cancer in Pregnant Rats and its Complications on the Ovaries.

Authors:  Abd El-Fattah B M El-Beltagy; Hassan I H Elsyyad; Karoline K Abdelaziz; Amira S Madany; Mohamed M Elghazaly
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-07-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.